6-Phosphogluconolactonase (PGLS), encoded by the PGLS gene in humans, is an enzyme involved in the pentose phosphate pathway (PPP), an essential metabolic pathway that generates NADPH and pentoses (5-carbon sugars).Specifically, PGLS catalyzes the second step of the PPP, the hydrolysis of 6-phosphogluconolactone to 6-phosphogluconate. This step is essential for the continuation of the pathway, which plays a critical role in cellular processes.The PPP has two primary functions: NADPH generation and the production of ribose-5-phosphate. NADPH is a key molecule for various cellular processes, including detoxification reactions, biosynthesis processes, and the maintenance of redox balance. Ribose-5-phosphate, on the other hand, is a precursor for the synthesis of nucleotides and nucleic acids, essential for DNA and RNA production.
Given its role in the PPP, PGLS is indirectly involved in these processes. Thus, it contributes to maintaining cellular health by supporting antioxidative defense, biosynthesis pathways, and nucleotide production.Alterations in the PPP and its enzymes, including PGLS, can lead to imbalances in cellular redox state and nucleotide synthesis, potentially contributing to various diseases, including cancer and neurodegenerative disorders.In summary, 6-phosphogluconolactonase is a crucial enzyme in the pentose phosphate pathway, contributing to antioxidant defense, biosynthesis processes, and nucleotide production.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Nicotinamide riboside | 1341-23-7 | sc-507345 | 10 mg | $411.00 | ||
NADPH precursors can enhance the overall flux through the PPP, potentially influencing PGLS activity. | ||||||
Hydrogen Peroxide | 7722-84-1 | sc-203336 sc-203336A sc-203336B | 100 ml 500 ml 3.8 L | $30.00 $60.00 $93.00 | 27 | |
Agents that induce oxidative stress can increase the demand for NADPH, indirectly influencing PGLS activity in the PPP. | ||||||
Metformin | 657-24-9 | sc-507370 | 10 mg | $77.00 | 2 | |
Metformin, known for its effects on glucose metabolism, could indirectly influence PGLS activity by altering PPP flux. | ||||||
L-Ascorbic acid, free acid | 50-81-7 | sc-202686 | 100 g | $45.00 | 5 | |
Antioxidants can reduce oxidative stress, potentially modulating the need for NADPH and influencing PGLS activity. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
mTOR inhibitors can affect cellular metabolism, including the PPP, potentially influencing PGLS activity. | ||||||
AICAR | 2627-69-2 | sc-200659 sc-200659A sc-200659B | 50 mg 250 mg 1 g | $60.00 $270.00 $350.00 | 48 | |
AMPK activators can modulate cellular energy metabolism, potentially affecting PPP flux and PGLS activity. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $60.00 $185.00 $365.00 | 64 | |
These compounds mimic the effects of caloric restriction, potentially affecting PPP flux and PGLS activity. | ||||||
Deferoxamine | 70-51-9 | sc-507390 | 5 mg | $250.00 | ||
Iron chelators can modulate oxidative stress and cellular metabolism, potentially influencing PGLS activity. | ||||||